Deletion of p18(INK4c) aggravates cisplatin-induced acute kidney injury

Liang Wang1, Wei Chen2, Yi Zhang2

  • 1Department of Urology, The Second Affiliated Hospital of Dalian Medical University, Dalian 116021, P.R. China.

Insights

The INK4 family member p18 (INK4c) protects against acute kidney injury (AKI). Deleting p18 worsened kidney damage and survival in cisplatin-induced AKI, suggesting p18

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cellular Stress Response

Background:

  • Cyclin-dependent kinase inhibitors (CDKIs) show protective effects in acute kidney injury (AKI).
  • Research on CDKIs in AKI has primarily focused on CIP/KIP family members.
  • The role of INK4 family members, specifically p18(INK4c) (p18), in AKI remains under-investigated.

Purpose of the Study:

  • To investigate the role of p18(INK4c) in cisplatin-induced acute kidney injury (AKI).
  • To evaluate the protective effects of p18 in a mouse model of AKI.
  • To explore the association between p18 expression and endoplasmic reticulum stress (ERS) in AKI.

Main Methods:

  • Utilized p18 gene knockout mice (p18-/-) and wild-type (p18+/+) littermates.
  • Induced AKI via a single intraperitoneal injection of cisplatin (12.5 mg/kg).
  • Assessed survival rates, renal function (e.g., serum creatinine, BUN), morphological kidney injuries, and endoplasmic reticulum stress markers (Western blot).

Main Results:

  • Mice lacking p18 (p18-/-) exhibited significantly reduced survival rates compared to wild-type mice (p18+/+) following cisplatin administration.
  • p18 deletion exacerbated renal function impairment and morphological damage in cisplatin-induced AKI.
  • The absence of p18 significantly aggravated endoplasmic reticulum stress (ERS) in the kidneys of AKI mice.

Conclusions:

  • p18(INK4c) exerts a protective role in cisplatin-induced acute kidney injury.
  • The protective mechanism of p18 may involve the regulation of cell death pathways, particularly endoplasmic reticulum stress.
  • These findings highlight p18 as a potential therapeutic target for AKI.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.4K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.4K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K